Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the efficacy of 16 weeks of chronic treatment with oral sildenafil in pediatric subjects, aged 1 to 17 years, with PAH. Primary efficacy will be measured by exercise tolerance, bicycle ergometry testing in those subjects who are developmentally able to perform the exercise paradigm as described in the protocol. Secondary efficacy will be assessed in all subjects as described in Section 6.4.1.2 of the protocol.
Critère d'inclusion
- pulmonary arterial hypertension